2 Biotech Firms To Pay $10M For Mischarging Fed Grants
Two biotech companies, iSense LLC and Specific Diagnostics, and their owner have agreed to pay more than $10 million to the U.S. to resolve False Claims Act allegations that they improperly...To view the full article, register now.
Already a subscriber? Click here to view full article